BackCorMedix Overview
CorMedix Inc

CorMedix Target Price

Analysts' average 12-month price target for CorMedix is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.28

Average Target Price

$14.0069.1% upside

1 analysts in the last 4 months

High: $14 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-28RBC CapitalLeonid Timashev$1469.1% upsideOpen
2026-03-06Leerink PartnersRoanna Ruiz$1357% upsideOpen
2026-01-23H.C. Wainwright$1357% upsideOpen
2026-01-21RBC Capital$1357% upsideOpen
2026-01-08Truist Financial$1693.2% upsideOpen
2025-10-21RBC CapitalGregory Renza$22165.7% upsideOpen
2025-08-08H.C. WainwrightBrandon Folkes$17105.3% upsideOpen
2024-03-13RBC CapitalGregory Renza$98.7% upsideOpen

CorMedix (CRMD) FAQ

CorMedix (CRMD) currently reports a target price of $14. Use the charts on this page to explore CorMedix's target price history and peer comparisons.

Analysts' average 12-month price target for CorMedix is $14, about 69.1% upside from the current share price of $8.28. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $14, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CorMedix, and consider following CRMD for alerts when major investors trade the stock.

CorMedix is classified in the Healthcare sector. On target price, it currently shows $14. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRMD with unrelated industries.